HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Start-Up Previews (07/2008)

Executive Summary

A preview of the emerging health care companies profiled in the current, all-profiles issue of Start-Up. This month's profile groups are "Glioblastoma Start-Ups Get Specific," "Glaucoma Start-Ups Reach Critical Mass," and "ALS on the Cusp." Plus these Start-Ups Across Health Care: EarlySense, NeoChord, and Pantec Biosolutions.

You may also be interested in...

EarlySense Ltd.

Israeli start-up EarlySense is a new entrant in the patient supervision and monitoring market. Its EverOn supervision system allows patients to be easily and continuously supervised without any physical contact or connections.

Sensimed AG

In the field of glaucoma, there are a lot of unknowns because it hasn't previously been feasible to continuously monitor intraocular pressure. Sensimed was formed to do just that. The young company is developing a sensor that would provide 24-hours worth of intraocular pressure data as an alternative to the point-by-point measurement systems available today. The company likens its device to the Holter monitor in cardiovascular disease-a device that can yield a comprehensive set of diagnostic data as a patient goes about his or her daily life.

NeoChord Inc.

NeoChord wants to enable less invasive mitral valve repair with the NeoChord DS1000 is a tool for implanting artificial chordae tendineae made of suturing material while the heart is still beating.

Related Content

Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts